Assessing health status quality of life in ALS: Comparison of the SIP/ALS-19 with the ALS functional rating scale and the short form-12 health survey™

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

Volumn 2, Issue 1, 2001, Pages 31-37

  Bromberg, Mark B ^a   Anderson, Fred ^b   Davidson, Matthew ^b   Miller, Robert G ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

ALS; Amyotrophic lateral sclerosis; Quality of life

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DATA BASE; DISEASE COURSE; FEMALE; HEALTH STATUS; HEALTH SURVEY; HUMAN; INSTRUMENT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; NORTH AMERICA; PRIORITY JOURNAL; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SOCIOLOGY;

EID: 0035023053     PISSN: 14660822     EISSN: None     Source Type: Journal    
DOI: 10.1080/146608201300079391     Document Type: Article

References (11)

1. Testa M, Simonson D. Assessment of quality-of-life outcomes. N Engl J Med 1996; 334: 220-233.
2. WFN Research Group on Neuromuscular Diseases: Subcommittee on Motor Neuron Disease. Airlie House guidelines: Therapeutic trials in amyotrophic lateral sclerosis. J Neurol Sci 1995; 129 (Suppl): 1-10.
3. ALS CNTF Treatment Study (ACTS) phase I-II Study Group. The amyotrophic lateral sclerosis functional rating scale. Arch Neurol 1996; 53: 141-147.
4. Ware J, Kosinski M, Keller S. A 12-item short-form health survey. Med Care 1996; 34: 220-233.
5. McGuire D, Garrison L, Armon C, et al. Relationship of the Tufts Quantitative Neuromuscular Exam (TQNE) and the Sickness Impact Profile (SIP) in measuring progression of ALS. Neurology 1996; 46: 1442-1444.
6. McGuire D, Garrison L, Armon C, et al. A brief quality-of-life measure for ALS clinical trials based on a subset of items from the Sickness Impact Profile. J Neurol Sci 1997; 152: S18-S22.
7. Miller R, Anderson F, Bradley W, et al. The ALS Patient Care Database: Goals, design, and early results. Neurology 2000; 54: 53-57.
8. Jenkinson C, Fitzpatrick R, Brennan C, Bromberg M, Swash M. Development and validation of a short measure of health status for individuals with amyotrophic lateral sclerosis/motor neurone disease: The ALSAQ-40. J Neurol 1999; 246 (suppl 3): III/16-III/21.
9. McDonald E, Wiedenfeld S, Hillel A, Carpenter C, Walter R. Survival in amyotrophic lateral sclerosis. Arch Neurol 1994; 51: 17-23.
10. Hickey A, Bury G, O'Boyle C, Bradley F, O'Kelly F, Shannon W. A new short form individual quality of life measure (SEIQoL-DW): application in a cohort of individuals with HIV/AIDS. Br Med J 1996; 313: 29-33.
11. Simmons Z, Bremer B, Robbins R, Walsh S, Fischer S. Quality of life in ALS depends on factors other than strength and physical function. Neurology 2000; 55: 388-392.